Research uncovers link between reproductive factors and COPD risk in women

A range of reproductive factors, including age when periods first start and an early menopause, are all linked to a heightened risk of COPD—the umbrella term for progressive lung conditions that cause breathing difficulties—finds research published online in the journal Thorax.

PD-1 inhibitors and systemic oncolytic viral immunotherapies under the spotlight at IO360 – Pharmaceutical Technology

Share this article An illustration of T cells attacking cancer cells. Image Credit: Shutterstock/Peddalanka Ramesh Babu During the 10th Annual Immuno-Oncology 360° (IO360) Conference on

March 20, 2024

Beckman Coulter Life Sciences and Rarity Bioscience AB Partnership Brings Molecular Research to Flow Cytometry

Innovative superRCA technology from Rarity Bioscience AB enhances flow cytometry, expanding oncology research possibilities and improving mutation detection.

March 5, 2025

FDA Approves Vorasidenib for IDH-Mutant Gliomas

The FDA approved vorasidenib (Voranigo) for patients 12 years and older with grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation. The

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.